Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors

Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors

Background Targeting epidermal growth factor receptor (EGFR) has become a strategic approach in cancer therapy, using various modalities including chimeric antigen receptor (CAR)-αβT cell therapies. Despite significant advancements in autologous CAR-αβT cell therapies in B-cell lymphoma, current cel...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi-Chiu Kuo, Hao-Kang Li, Tai-Sheng Wu, Ying Ru, Chia-Yun Lee, Pei-Ju Leng, Yi-Chun Hsieh, Yun-Jung Chiang, Zih-Fei Cheng, Yan-Liang Lin, Shih-Chia Hsiao, Sai-Wen Tang
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-07-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/7/e010500.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab
by: Roberto Benelli, et al.
Published: (2022-12-01)

Effects of functional antioxidants on the expansion of gamma delta T-cells and their cellular cytotoxicity against bladder cancer cells
by: Yueh Pan, et al.
Published: (2025-06-01)

Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma
by: Chaeyeon Kim, et al.
Published: (2025-03-01)

EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer
by: Jiefu Zhou, et al.
Published: (2025-03-01)

Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma
by: Wen-Chen Tang, et al.
Published: (2023-07-01)

ADI-270: an armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignancies
by: Jie Zhang, et al.
Published: (2025-07-01)

Cetuximab and Cisplatin Show Different Combination Effect in Nasopharyngeal Carcinoma Cells Lines via Inactivation of EGFR/AKT Signaling Pathway
by: Jiajia Gu, et al.
Published: (2016-01-01)

Gamma Delta (γδ) T Cells and Their Involvement in Behçet’s Disease
by: Md. Samiul Hasan, et al.
Published: (2015-01-01)

GAMMA DELTA (γδ) T CELLS: ORIGIN, PHENOTYPE, FUNCTIONS
by: Dmitry Sokolov
Published: (2019-08-01)

Co-targeting TMEM16A with a novel monoclonal antibody and EGFR with Cetuximab inhibits the growth and metastasis of esophageal squamous cell carcinoma
by: Yutian Zheng, et al.
Published: (2024-11-01)

ROLE OF GAMMA DELTA T CELLS IN THE IMMUNE RESPONSE TO MYCOBACTERIUM TUBERCULOSIS
by: E. G. Churina, et al.
Published: (2014-03-01)

Letter to the Editor: EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer
by: Hinpetch Daungsupawong PhD, et al.
Published: (2024-10-01)

Targeted siRNA Delivery Using Cetuximab‐Conjugated Starch for Epidermal Growth Factor Receptor‐Driven Head and Neck Squamous Cell Carcinoma
by: Chen Benafsha, et al.
Published: (2025-07-01)

Targeting FABP4/UCP2 axis to overcome cetuximab resistance in obesity-driven CRC with drug-tolerant persister cells
by: Yi-Chiao Cheng, et al.
Published: (2025-03-01)

Inhalable Anti-EGFR Antibody-Conjugated Osimertinib Liposomes for Non-Small Cell Lung Cancer
by: Apoorva Daram, et al.
Published: (2024-11-01)

Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM)
by: Rethinam Senthil, et al.
Published: (2024-03-01)

Uncovering the mysteries of human gamma delta T cells: from origins to novel therapeutics
by: Sylwia Biały, et al.
Published: (2025-04-01)

Hepatosplenic Gamma Delta T cell Lymphoma in a Young Male with Visceral Leishmaniasis
by: Deepti Mutreja, et al.
Published: (2014-08-01)

Comparative Gamma Delta T Cell Immunology: A Focus on Mycobacterial Disease in Cattle
by: Brandon L. Plattner, et al.
Published: (2011-01-01)

Gamma delta T cells in acute myeloid leukemia: biology and emerging therapeutic strategies
by: Venkata Lokesh Battula, et al.
Published: (2024-02-01)

Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanism
by: Bartlomiej Taciak, et al.
Published: (2025-02-01)

Cetuximab and Paclitaxel Drug Response in Head and Neck Tumor Stem Cells
by: Vilson Serafim Júnior, et al.
Published: (2025-02-01)

Prostate-Specific Membrane Antigen-Targeted Antibody–Drug Conjugates: A Promising Approach for Metastatic Castration-Resistant Prostate Cancer
by: Chia-Hsien Shih, et al.
Published: (2025-03-01)

Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab
by: Xuefeng Wang, et al.
Published: (2025-03-01)

A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan
by: Weiyi Qiu, et al.
Published: (2019-01-01)

Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Purvish M. Parikh, et al.
Published: (2025-01-01)

Pneumatosis Cystoides Intestinalis after Cetuximab Chemotherapy for Squamous Cell Carcinoma of Parotid Gland
by: Christos Petrides, et al.
Published: (2015-01-01)

EGFR gene copy number as a prognostic marker in colorectal cancer patients treated with cetuximab or panitumumab: a systematic review and meta analysis.
by: Zheng Jiang, et al.
Published: (2013-01-01)

Primary Cutaneous Gamma–Delta T-Cell Lymphoma Presenting With Hemophagocytic Lymphohistiocytosis in a Young Polynesian Male
by: Saeed Arabi, et al.
Published: (2025-01-01)

Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling
by: Hong Xia, et al.
Published: (2025-02-01)

AI-driven fall risk prediction in inpatients: Development, validation, and comparative evaluation
by: Chia-Lun Lo, et al.
Published: (2025-03-01)

Single‐cell sequencing analysis reveals cetuximab resistance mechanism and salvage strategy in colorectal cancer
by: Shiyun Chen, et al.
Published: (2025-01-01)

The role of cetuximab in the treatment of patients with squamous cell carcinoma of the head and neck: resolution of the Expert Council
Published: (2019-01-01)

Critical Review: Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer
by: Anita Ramesh
Published: (2025-07-01)

Regulatory T-cells and allogeneic hematopoietic stem cell transplantation
by: O. S. Karavaeva, et al.
Published: (2022-12-01)

Characteristics of ${\alpha g}_{(\gamma,\delta )}$-Irresolute Maps
by: Justin Jasmine Mershia Rabuni, et al.
Published: (2025-04-01)

Improved Biological Impacts of Anti-EGFR Monoclonal Antibody in KRAS-Mutant Colorectal Cancer Cells by Silica-Coated Magnetic Nanoparticle Conjugation
by: Maedeh Yousefi, et al.
Published: (2024-10-01)

The Different Effects of Atorvastatin and Pravastatin on Cell Death and PARP Activity in Pancreatic NIT-1 Cells
by: Ya-Hui Chen, et al.
Published: (2016-01-01)

EGFR phosphorylates DNAJB1 to suppress α-synuclein aggregation in Parkinson’s disease
by: Yun-Yu Huang, et al.
Published: (2025-06-01)

Reply to: Critical Review: Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer
by: Kumar Prabhash, et al.
Published: (2025-07-01)